The Deubiquitinase A20 Mediates Feedback Inhibition of Interleukin-17 Receptor Signaling
Open accessThe DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Abstract
The proinflammatory cytokine interleukin-17 (IL-17) is the signature cytokine of the T helper 17 (TH17) subset of CD4(+) T cells, and antibodies targeting IL-17 or the IL-17 receptor (IL-17R) show clinical efficacy in several autoimmune diseases. Although important for protective immunity against microorganisms, IL-17 causes collateral damage in inflammatory settings. TNFAIP3 encodes the deubiquitinase A20 and is genetically linked to numerous autoimmune syndromes. A20, a potent inhibitor of tumor necrosis factor-α signaling, removes ubiquitin from signaling intermediates upstream of nuclear factor κB (NF-κB), thereby dampening NF-κB-mediated inflammation. We demonstrated that IL-17 stimulates TNFAIP3 expression. Enhanced IL-17-mediated induction of genes encoding proinflammatory factors, including IL-6 and various chemokines, occurred upon knockdown of A20 with short inhibitory RNA or in A20(-/-) cells. A20 associated with the E3 ubiquitin ligase TRAF6 (tumor necrosis factor receptor-associated factor 6) in an IL-17-dependent manner and restricted the IL-17-dependent activation of NF-κB and mitogen-activated protein kinases. A20 interacted directly with the distal domain of IL-17RA, a previously defined inhibitory domain. Together, these data describe a mechanism of restraining IL-17 signaling and reveal an aspect of A20 activity that may help to explain its role in autoimmunity in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“IL-17-NF-κB signaling induces several negative feedback circuits that restrain NF-κB activation, including deubiquitinating enzymes or related factors, including A20 (TNFAIP3), Abin-1 (TNIP1) and USP25”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Garg et al., 2013
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873 · cited 2×
“IL-17 is produced by a subset of CD4 T cells termed T helper 17 (TH17) cells, and a fast-moving body of literature has described the many mechanisms by which TH17 cells are generated and regulated (6, 7).”
BackgroundHarrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039 · cited 1×
“Conversely, excess IL-17 is associated with numerous autoimmune diseases, and many genes identified as risk loci for autoimmunity in genome-wide association studies (GWAS) (for example, IL23R and STAT3) are associated with regulation of IL-17 or the TH17 differentiation pathway (13, 14).”
BackgroundCytokines in the pathogenesis of rheumatoid arthritis
McInnes, I. B., & Schett, G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2094 · Cited by 2,529 · cited 1×
“Inflammatory cytokines, such as tumor necrosis factor–a (TNF-a), have long been recognized to promote the pathogenesis of devastating autoimmune diseases, such as rheumatoid arthritis (RA), among many others (1).”
BackgroundDe-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
Wertz, I. E., O'Rourke, K. M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R., Boone, D. L., et al. (2004) · Nature · doi:10.1038/nature02794 · Cited by 1,856 · cited 3×
“The primary enzymatic function of A20 is to serve as a DUB, although it can also act as a ubiquitin ligase and inhibit signaling independently of its catalytic activity (32, 36, 55, 80).”
BackgroundSelf-citationIL-17 family cytokines and the expanding diversity of effector T cell lineages
Weaver, C. T., Hatton, R. D., Mangan, P. R., & Harrington, L. E. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141557 · Cited by 1,842 · cited 1×
“Since the discovery of the TH17 subset of helper T cells in 2005, considerable attention has been paid to how TH17 and other IL-17–producing cells are generated and maintained but far less to how IL-17 mediates downstream signaling (6, 62).”
BackgroundInnate IL-17-producing cells: the sentinels of the immune system
Cua, D. J., & Tato, C. M. (2010) · Nature Reviews Immunology · doi:10.1038/nri2800 · Cited by 1,578
Interleukin-2 Signaling via STAT5 Constrains T Helper 17 Cell Generation
Laurence, A., Tato, C. M., Davidson, T. S., Kanno, Y., Chen, Z., Yao, Z., Blank, R. B., Meylan, F., Siegel, R., Hennighausen, L., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.02.009 · Cited by 1,507
Structure and signalling in the IL-17 receptor family
Gaffen, S. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2586 · Cited by 1,475 · cited 8×
“A20 inhibits the IL-17–dependent activation of MAPK signaling, particularly the c-Jun N-terminal kinase pathway In the IL-17 signaling pathway, TRAF6 is required for the activation of MAPKs (15).”
BackgroundSelf-citation
Cited by
Items 101–130 of 130
Regulation of Interleukin-17 Production
Dong, W., & Ma, X. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-94-024-0921-5_7 · Cited by 7
Act1 drives chemoresistance via regulation of antioxidant RNA metabolism and redox homeostasis
Hong, L., Herjan, T., Chen, X., Zagore, L. L., Bulek, K., Wang, H., Yang, C. J., Licatalosi, D. D., Li, X., & Li, X. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20231442 · Cited by 5
Liang, J., Zhang, J. J., Huang, H.-I., Kanayama, M., Youssef, N., Jin, Y. J., Reyes, E. Y., Abram, C. L., Yang, S., Lowell, C. A., et al. (2020) · Infection and Immunity · doi:10.1128/iai.00048-20 · Cited by 5
Wang, X., Xiao, Y., Dong, Y., Wang, Z., Yi, J., Wang, J., Wang, X., Zhou, H., Zhang, L., & Shi, Y. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00562-2 · Cited by 8
“Thus, the enzymatic activity of A20 is mainly performed by the OTU and ZnF4 domains [5, 6].”
BackgroundAdipose Tissue Macrophage-Mediated Inflammation in Obesity: A Link to Posttranslational Modification
Wei, D., Tian, X., Zhai, X., & Sun, C. (2023) · Immunological Investigations · doi:10.1080/08820139.2023.2205883 · Cited by 4
“A20 associates with the E3 ubiquitin ligase TRAF6 in an IL-17–dependent manner and restricts the IL-17–dependent activation of NF-κB and mitogen-activated protein kinases (Garg et al. 2013).”
BackgroundWang, X., Yu, S., Gao, Z., Xu, F., Wang, Y., Zhang, T., Xie, T., & Jia, X. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1539038 · Cited by 4
Interleukin-17A (IL-17A): Molecular Mechanisms and Its Roles in Immune and Neuroimmune Systems
Sanaka, S., Kubo, A., Kamiya, S., Nakamura, K., & Sasaki, T. (2026) · Receptors · doi:10.3390/receptors5020016 · Cited by 4
“Genome-wide association studies have identified multiple susceptibility loci that converge on the IL-23/IL-17 pathway, including IL23R, IL12B, TNFAIP3 (encoding A20), and TRAF3IP2 (encoding Act1), providing human genetic evidence for the causal role of this axis in psoriasis [29].”
Momoh, M., Adeniran, F., Ramos, C., DelGiorno, K. E., Seno, H., Roland, J. T., & Kaji, I. (2025) · Physiological Reports · doi:10.14814/phy2.70264 · Cited by 3
“…length and tuft cell number has been identified in another mouse model: the deletion of A20, a deubiquitinase, which inhibits the release of IL-13 from ILC2s, leads to constitutive activation of the type-2 immune response and, subsequently, results in tuft cell hyperplasia (Garg et al., 2013).”
The research potential of A20 in psoriatic arthritis
Wan, Y. W., Duan, X., Jin, Z., & Chen, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1630198 · Cited by 2
“The therapeutic reduction of TNF-a consequently diminishes A20 levels, impairing its capacity to suppress IL-17A and creating a permissive environment for IL-17-driven in fl ammation (64, 124, 125).”
InfluentialSong, Y., Huang, X., Wei, L., Shen, W., Gao, J., Hou, K., Yang, B., Wang, Y. H., Hu, G., Xu, W., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2426265123 · Cited by 3
“TRAF3 and A20, both known signaling inhibitors, are associated with the CBAD (19, 35).”
Saleh, A. A., Shehata, W. A., Abd-Elhafiz, H. I., & Soliman, S. E.-S. (2021) · Meta Gene · doi:10.1016/j.mgene.2021.101002 · Cited by 2
A20 as a Potential Therapeutic Target for COVID‐19
Wu, Y., Li, H., Li, R., Li, J., Zhao, Q., & Shao, B. (2025) · Immunity Inflammation and Disease · doi:10.1002/iid3.70127 · Cited by 2
Verdier, J., & Ruemmele, F. M. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.829471 · Cited by 2
“[75] Garg AV, Ahmed M, Vallejo AN, et al.”
BackgroundInfluentialFine-tuning immunity: ubiquitin-dependent regulation of interleukin-17A expression by Th17 cells
Raj, D., Verma, A. K., Mathur, R., Woody, J., Kathania, M., & Venuprasad, K. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1614409 · Cited by 2
“A20, a deubiquitinase, also fi ne-tunes IL-17A signaling (56).”
Five children with haploinsufficiency of A20 caused by heterozygous mutations in the TNFAIP3 gene
Yao, H., Liu, Y., Dong, M., Yang, K., Yu, Z., & Zhou, F. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1738656 · Cited by 1
Nolin, J. D. (2015) · ScholarWorks -A service of University of Vermont Libraries (University of Vermont) · Cited by 1
Lai, Y., & Dong, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.10014-1 · Cited by 1
Weiss, L. M. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727383847.793562576 · Cited by 1
Heger, K.-D. (2014) · MPG.PuRe (Max Planck Society) · doi:10.5282/edoc.17240 · Cited by 1
FEEDBACK INHIBITION OF IL-17 RECEPTOR SIGNAL TRANSDUCTION
Garg, A. V. (2014) · D-Scholarship@Pitt (University of Pittsburgh)
Self-citationSheehan, R. P. (2016) · D-Scholarship@Pitt (University of Pittsburgh)
FUNCTIONAL REGULATION OF INTERLEUKIN-17 RECEPTOR SIGNALING
Cruz, J. A. (2018) · D-Scholarship@Pitt (University of Pittsburgh)
Tram, C. (2018) · DalSpace (Dalhousie University)
Genetic basis of chronic mucocutaneous candidiasis disease in humans
Lévy, R. (2017) · theses.fr (ABES) · doi:10.70675/fbe0154ez44e5z43ccza33azb697756b8b48
The roles of MCPyV early region in IL-17A-mediated inflammation and autophagy
Miao, J. (2021) · theses.fr (ABES) · doi:10.70675/0ed263f9za522z491ezb888z3d6d2826cd2b
Lai, Y., & Dong, C. (2025) · Elsevier eBooks · doi:10.1016/b978-0-128-24465-4.00090-9
Maffezzoni, M. B. R., Moretti, F., Botti, E., Marinari, B., Rusin, M., Narcisi, A., Favaro, R., & Costanzo, A. (2026) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2026.07.004
Liu, Y., Li, L., Wang, C., Zhu, X., Cheng, K., & Sun, X. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2026.120204
Th17 cells and IL-17A in traumatic brain injury: mechanisms and therapeutic perspectives
Guo, X., Wang, J., Zhu, S., Sun, B., Tian, L., Li, M., Feng, S., & Sun, G. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1850719 · Cited by 1
“Conversely, negative regulators including A20, TRAF3, and soluble IL-17RA isoforms serve to restrain IL-17 receptor signaling and prevent excessive in fl ammatory activation (73 – 75).”
Deubiquitinases at the crossroads of T-cell immunity and tumor immune evasion
Iyer, R., Tang, A. Y., & Fang, D. (2026) · Cellular and Molecular Immunology · doi:10.1038/s41423-026-01487-8
Metadata
- Authors
- Garg, A. V., Ahmed, M., Vallejo, A. N., Ma, A., & Gaffen, S. L.
- Affiliations
- University of Pittsburgh (US)
- University of California, San Francisco (US)
- Corresponding author
- Gaffen, Sarah L.
- Venue
- Science Signaling
- Published
- 2013-06-04
- Volume
- 6
- Issue
- 278
- Pages
- ra44-ra44
- ISSN
- 1937-9145 (ISSN-L)
- 1945-0877
- PMC
- PMC4028484
- OpenAlex
- W2103961090
- Cited by
- 128
- References
- 88
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 7 · 2023: 5 · 2022: 8 · 2021: 9 · 2020: 14 · 2019: 13 · 2018: 11 · 2017: 12 · 2016: 11 · 2015: 6 · 2014: 12 · 2013: 6
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science Signaling (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK095693, P30DK026743)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR054389, R01AR054389)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- A20, IL-17, IL-17 receptor signaling, TRAF6, E3 ubiquitin ligase, NF-κB activation, product inhibition, inflammatory cytokines, interleukin-6, chemokines, mitogen-activated protein kinase, autoimmunity, Th17 cells
- MeSH terms
- Humans, Promoter Regions, Genetic, Signal Transduction, NF-kappa B, TNF Receptor-Associated Factor 6, Receptors, Interleukin-17, Ubiquitin-Specific Proteases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.